1,2-Dichloroethane → HCID 178521727, compound
Reaction equation
[F:1][C:2]1([F:8])[CH2:4][CH:3]1[C:5](O)=[O:6].N1(O)C2C=CC=CC=2N=N1.C(Cl)CCl.C(=O)(O)[O-].[Na+].[O:28]1[CH2:33][CH2:32][N:31]([C:34]2[CH:58]=[CH:57][C:37]3[NH:38][C:39]([C:41]4[C:49]5[C:44](=[CH:45][CH:46]=[C:47]([NH2:50])[CH:48]=5)[N:43]([CH:51]5[CH2:56][CH2:55][CH2:54][CH2:53][O:52]5)[N:42]=4)=[N:40][C:36]=3[CH:35]=2)[CH2:30][CH2:29]1>CN(C=O)C>[F:1][C:2]1([F:8])[CH2:4][CH:3]1[C:5]([NH:50][C:47]1[CH:48]=[C:49]2[C:44](=[CH:45][CH:46]=1)[N:43]([CH:51]1[CH2:56][CH2:55][CH2:54][CH2:53][O:52]1)[N:42]=[C:41]2[C:39]1[NH:38][C:37]2[CH:57]=[CH:58][C:34]([N:31]3[CH2:32][CH2:33][O:28][CH2:29][CH2:30]3)=[CH:35][C:36]=2[N:40]=1)=[O:6]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
2,2-Difluorocyclopropanecarboxylic acid (6.42 mg, 0.053 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (9.69 mg, 0.072 mmol), EDC (13.74 mg, 0.072 mmol) and sodium bicarbonate (4.01 mg, 0.048 mmol) was added to a solution of 3-(5-morpholino-1H-benzo[d]imidazol-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-amine (20 mg, 0.048 mmol) in DMF (6 mL). The reaction mixture was stirred at room temperature for 24 h, and then the solvent was removed in vacuo. Upon purification by flash chromatography (6% CH3OH/CH2Cl2) afforded the title compound (15 mg). 1H NMR: (400 MHz, CD3OD): δ 8.51 (s, 1H), 7.76-7.72 (m, 1H), 7.68 (m, 1H), 7.58 (m, 1H), 7.05 (m, 2H), 5.86 (dd, 1H, J=2.4 and 9.6 Hz), 3.99 (m, 1H), 3.86 (m, 4H), 3.81 (m, 1H), 3.16 (m, 4H), 2.77-2.69 (m, 1H), 2.61 (m, 1H), 2.18-2.08 (m, 3H), 1.89-1.80 (m, 2H), 1.74-1.68 (m, 2H); ESI-MS [M+H]+: 523.2.
Workup
- customthe solvent was removed in vacuo
- customUpon purification by flash chromatography (6% CH3OH/CH2Cl2)
Sources & evidence
- ORD record
- ord-b84fdbebd66e45c594accb76d84e42e5
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08569511B2
Reaction notes
Loading…